Integrated BioPharma, Inc. (INBP)
OTCMKTS · Delayed Price · Currency is USD
0.1600
0.00 (0.00%)
At close: Nov 19, 2026
Integrated BioPharma Revenue
Integrated BioPharma had revenue of $9.91M in the quarter ending September 30, 2026, a decrease of -21.88%. This brings the company's total for the last twelve months to $41.10M, down -23.08% year-over-year. In the fiscal year ending June 30, 2026, Integrated BioPharma had annual revenue of $43.87M, down -19.28%. That makes Integrated BioPharma the 29,396th largest company in the world by revenue and 3,899th in the United States.
Revenue (ttm)
41.10M
Revenue Growth
-23.08%
P/S Ratio
0.12
Revenue / Employee
306.69K
Employees
134
Market Cap
4.97M
Revenue by Segment
Fiscal year ended Jun 30, 2026 See the full Integrated BioPharma breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 43.87M | -10.48M | -19.28% |
| Jun 30, 2025 | 54.35M | 4.04M | 8.02% |
| Jun 30, 2024 | 50.32M | -355.00K | -0.70% |
| Jun 30, 2023 | 50.67M | -5.57M | -9.91% |
| Jun 30, 2022 | 56.25M | -7.31M | -11.51% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cyanotech | 25.27M |
| BAB, Inc. | 3.54M |
| Glucose Health | 1.11M |
| Next Meats Holdings | 1.05M |
| Bell Buckle Holdings | 1.02M |
| Limitless X Holdings | 287.57K |
| Strake | 223.07K |
| Wenyuan Group | 24.63K |
Integrated BioPharma News
- 1 month ago - Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2026 - Accesswire
- 6 months ago - Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026 - Accesswire
- 9 months ago - Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025 - Accesswire
- 11 months ago - Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions - GlobeNewsWire
- 1 year ago - Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2025 - Accesswire
- 1 year ago - Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025 - Accesswire
- 1 year ago - Integrated BioPharma Reports Results for its Quarter Ended March 31, 2025 - Accesswire
- 1 year ago - Integrated BioPharma Reports Results for its Quarter Ended December 31, 2024 - Accesswire